Literature DB >> 11358491

p300/CBP/p53 interaction and regulation of the p53 response.

S R Grossman1.   

Abstract

Substantial evidence points to a critical role for the p300/CREB binding protein (CBP) coactivators in p53 responses to DNA damage. p300/CBP and the associated protein P/CAF bind to and acetylate p53 during the DNA damage response, and are needed for full p53 transactivation as well as downstream p53 effects of growth arrest and/or apoptosis. Beyond this simplistic model, p300/CBP appear to be complex integrators of signals that regulate p53, and biochemically, the multipartite p53/p300/CBP interaction is equally complex. Through physical interaction with p53, p300/CBP can both positively and negatively regulate p53 transactivation, as well as p53 protein turnover depending on cellular context and environmental stimuli, such as DNA damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358491     DOI: 10.1046/j.1432-1327.2001.02226.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  69 in total

1.  Transcription coactivator CBP has direct DNA binding activity and stimulates transcription factor DNA binding through small domains.

Authors:  Chao Zhong Song; Kimberly Keller; Yangchao Chen; Ken Murata; George Stamatoyannopoulos
Journal:  Biochem Biophys Res Commun       Date:  2002-08-09       Impact factor: 3.575

2.  The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.

Authors:  David Dornan; Harumi Shimizu; Lindsay Burch; Amanda J Smith; Ted R Hupp
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  Mechanisms of p53 activation and physiological relevance in the developing kidney.

Authors:  Karam Aboudehen; Sylvia Hilliard; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-11

4.  Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.

Authors:  Nicolas Reynoird; Brian E Schwartz; Manuela Delvecchio; Karin Sadoul; David Meyers; Chandrani Mukherjee; Cécile Caron; Hiroshi Kimura; Sophie Rousseaux; Philip A Cole; Daniel Panne; Christopher A French; Saadi Khochbin
Journal:  EMBO J       Date:  2010-07-30       Impact factor: 11.598

5.  HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses.

Authors:  Edwige Col; Cécile Caron; Christine Chable-Bessia; Gaelle Legube; Sylvie Gazzeri; Yasuhiko Komatsu; Minoru Yoshida; Monsef Benkirane; Didier Trouche; Saadi Khochbin
Journal:  EMBO J       Date:  2005-07-07       Impact factor: 11.598

6.  ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.

Authors:  Remy Pedeux; Sagar Sengupta; Jiang Cheng Shen; Oleg N Demidov; Shin'ichi Saito; Hitoshi Onogi; Kensuke Kumamoto; Stephen Wincovitch; Susan H Garfield; Mary McMenamin; Makoto Nagashima; Steven R Grossman; Ettore Appella; Curtis C Harris
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

7.  Multitasking C2H2 zinc fingers link Zac DNA binding to coordinated regulation of p300-histone acetyltransferase activity.

Authors:  Anke Hoffmann; Thomas Barz; Dietmar Spengler
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  Multivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damage.

Authors:  Armin M Gamper; Robert G Roeder
Journal:  Mol Cell Biol       Date:  2008-02-04       Impact factor: 4.272

9.  Epigenetic mechanisms of Rubinstein-Taybi syndrome.

Authors:  Elizabeth Park; Yunha Kim; Hyun Ryu; Neil W Kowall; Junghee Lee; Hoon Ryu
Journal:  Neuromolecular Med       Date:  2014-01-01       Impact factor: 3.843

Review 10.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.